Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Topics
- Genetic association studies
- Typical design for an association study
- SNP genotype data from an association study
- Genome-wide association studies (1)
- Genome-wide association studies (2)
- Genome-wide association studies (3)
- Graphical representation of one/two-stage design
- Analyzing two-stage designs
- Genome-wide false positive rate
- Calculating power for two-stage designs
- Stage 1: selecting SNPs for follow-up (1)
- Stage 1: selecting SNPs for follow-up (2)
- Stage 2: replication based analysis (1)
- Stage 2: replication based analysis (2)
- Stage 2: joint analysis (1)
- Stage 2: joint analysis (2)
- Replication-based and joint analysis critical values
- Which analysis is more powerful?
- Which is more powerful? - results
- How power changes with proportion of samples?
- Effect of pi-samples on power
- How power changes with proportion of SNPs?
- Effect of pi-markers on power
- Between-stage heterogeneity influence on power
- Effect of between-stage heterogeneity on power
- Take home points
- Designing optimal two-stage GWA studies
- Assumptions
- Determining the optimal two-stage design
- One-stage power preserved in two-stage designs
- Cost and power of two-stage designs: R = 1
- Cost and power of two-stage designs: R = 5
- Cost ratio changes optimal two-stage designs
- What happens when cost ratio is misspecified?
- Misspecifying cost ratio has minor effect
- Strategies for further reducing GWA cost
- Reduce cost by decresing pi-power
- Reduce cost by relaxing alpha-marker
- Increasing power by relaxing alpha-marker
- Using custom arrays in stage 2
- Custom array cost structure
- Optimal two-stage designs using custom arrays
- Custom array example
- Admissible pi-markers
- Comparing optimal designs
- Summary (1)
- Summary (2)
- Acknowledgements
- References
Topics Covered
- Introduction to genome-wide association studies (GWAs)
- Construction, analysis and power of two-stage GWAs
- Designing optimal two-stage GWAs
- Strategies for further reducing the cost of two-stage GWAs
- Handling custom arrays when designing optimal GWA
Talk Citation
Skol, A. (2007, October 1). Two-stage genome-wide association designs [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/DJTL3597.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Andrew Skol has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.